Gilman Hill Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,579
Closed -$290K 228
2025
Q4
$290K Hold
1,579
0.05% 185
2025
Q3
$242K Hold
1,579
0.04% 202
2025
Q2
$221K Buy
+1,579
New +$221K 0.04% 213
2024
Q4
Sell
-1,852
Closed -$289K 221
2024
Q3
$289K Buy
1,852
+563
+44% +$90.9K 0.05% 179
2024
Q2
$201K Sell
1,289
-563
-30% -$84.7K 0.04% 202
2024
Q1
$251K Buy
+1,852
New +$245K 0.05% 188
2023
Q3
Sell
-1,852
Closed -$265K 206
2023
Q2
$265K Hold
1,852
0.05% 176
2023
Q1
$257K Hold
1,852
0.05% 177
2022
Q4
$251K Sell
1,852
-1,015
-35% -$127K 0.05% 186
2022
Q3
$314K Sell
2,867
-125
-4% -$15.9K 0.07% 166
2022
Q2
$395K Buy
2,992
+750
+33% +$98.4K 0.08% 150
2022
Q1
$297K Hold
2,242
0.07% 170
2021
Q4
$261K Hold
2,242
0.06% 189
2021
Q3
$269K Buy
+2,242
New +$261K 0.07% 177
2019
Q1
Sell
-2,925
Closed -$222K 189
2018
Q4
$222K Hold
2,925
0.09% 153
2018
Q3
$231K Hold
2,925
0.09% 152
2018
Q2
$205K Buy
+2,925
New +$210K 0.08% 160

Other funds holding AZN